By Landon Gray
The COVID-19 pandemic had a significant impact on hospital-acquired infections (HAIs), specifically methicillin-resistant Staphylococcus aureus (MRSA), leading the Society of Healthcare Epidemiology of America (SHEA) to look at its guidelines and consider revisions, according to presentations at IDWeek 2022, in Washington, D.C.
SHEA regularly updates its compendiums, although the timing of this update is fortuitous given the significant increase in laboratory-identified MRSA